ChNPs can work by delivering anticancer drug to all widely use cancer cells that repre-sent all type breast cancer ER (estrogen receptor), PR (progesterone receptor), and Her2 (human epidermal receptor 2) and triple negative breast cancer. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.